Ryuya Edahiro

2.4k total citations
19 papers, 156 citations indexed

About

Ryuya Edahiro is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Ryuya Edahiro has authored 19 papers receiving a total of 156 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 4 papers in Immunology. Recurrent topics in Ryuya Edahiro's work include Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Treatments and Mutations (3 papers) and Genetic Associations and Epidemiology (2 papers). Ryuya Edahiro is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Treatments and Mutations (3 papers) and Genetic Associations and Epidemiology (2 papers). Ryuya Edahiro collaborates with scholars based in Japan, Sweden and United Kingdom. Ryuya Edahiro's co-authors include Masahide Mori, Masaki Kanazu, Kohei Nishida, Mikako Ishijima, Takeshi Uenami, Yuki Akazawa, Yukihiro Yano, Mari Miki, Kazuyuki Tsujino and Kenji Yoshimura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Ryuya Edahiro

17 papers receiving 152 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryuya Edahiro Japan 9 78 60 30 24 24 19 156
Shôichi Ihara Japan 8 69 0.9× 63 1.1× 28 0.9× 26 1.1× 21 0.9× 20 148
Chiaki Hosoda Japan 7 115 1.5× 47 0.8× 18 0.6× 17 0.7× 11 0.5× 18 163
T. De Greslan France 7 55 0.7× 73 1.2× 18 0.6× 32 1.3× 10 0.4× 27 187
Marie-Christine Copin France 5 57 0.7× 25 0.4× 30 1.0× 18 0.8× 24 1.0× 6 194
Gabriel O Ologun United States 7 32 0.4× 72 1.2× 8 0.3× 30 1.3× 19 0.8× 25 176
Aya Wakabayashi Japan 6 73 0.9× 27 0.5× 35 1.2× 4 0.2× 14 0.6× 9 151
Machiko Kusuda Japan 8 15 0.2× 56 0.9× 37 1.2× 13 0.5× 29 1.2× 38 152
Kai-Hsiang Shu Taiwan 6 22 0.3× 20 0.3× 26 0.9× 7 0.3× 61 2.5× 9 145
Sara Bosio Italy 6 15 0.2× 76 1.3× 9 0.3× 16 0.7× 20 0.8× 14 148
Yahveth Cantero‐Fortiz Mexico 9 20 0.3× 31 0.5× 30 1.0× 52 2.2× 12 0.5× 28 206

Countries citing papers authored by Ryuya Edahiro

Since Specialization
Citations

This map shows the geographic impact of Ryuya Edahiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuya Edahiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuya Edahiro more than expected).

Fields of papers citing papers by Ryuya Edahiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuya Edahiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuya Edahiro. The network helps show where Ryuya Edahiro may publish in the future.

Co-authorship network of co-authors of Ryuya Edahiro

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuya Edahiro. A scholar is included among the top collaborators of Ryuya Edahiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuya Edahiro. Ryuya Edahiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Nishide, Masayuki, Hiroaki Matsushita, S. Kawada, et al.. (2025). Neutrophil single-cell analysis identifies a type II interferon-related subset for predicting relapse of autoimmune small vessel vasculitis. Nature Communications. 16(1). 3581–3581. 3 indexed citations
2.
3.
Yamamoto, Yuji, Yuya Shirai, Ryuya Edahiro, Atsushi Kumanogoh, & Yukinori Okada. (2024). Large-scale cross-trait genetic analysis highlights shared genetic backgrounds of autoimmune diseases. Immunological Medicine. 48(1). 1–10. 2 indexed citations
4.
Wang, Qingbo S., Ryuya Edahiro, Ho Namkoong, et al.. (2023). Estimating gene-level false discovery probability improves eQTL statistical fine-mapping precision. NAR Genomics and Bioinformatics. 5(4). lqad090–lqad090.
5.
Søndergaard, Jonas Nørskov, Ryuya Edahiro, Yuya Shirai, et al.. (2023). A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients. Proceedings of the National Academy of Sciences. 120(4). e2217902120–e2217902120. 10 indexed citations
6.
Nishide, Masayuki, Hiroaki Matsushita, Ryuya Edahiro, et al.. (2023). Single-cell multi-omics analysis identifies two distinct phenotypes of newly-onset microscopic polyangiitis. Nature Communications. 14(1). 5789–5789. 13 indexed citations
7.
Namkoong, Ho, et al.. (2023). DOCK2 Is Involved in the Host Genetics and Biology of Severe COVID-19. A3812–A3812. 1 indexed citations
8.
Kitada, Seigo, Ryuya Edahiro, Kazuyuki Tsujino, et al.. (2020). Characteristic chest CT findings for progressive cavities in Mycobacterium avium complex pulmonary disease: a retrospective cohort study. Respiratory Research. 21(1). 10–10. 20 indexed citations
9.
Arai, Toru, Hiroshi Kida, Yoshitaka Ogata, et al.. (2019). Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumonias. Respirology. 24(7). 658–666. 10 indexed citations
10.
Edahiro, Ryuya, Mikako Ishijima, Kohei Nishida, et al.. (2019). Continued administration of pembrolizumab for adenocarcinoma of the lung after the onset of fulminant type 1 diabetes mellitus as an immune‐related adverse effect: A case report. Thoracic Cancer. 10(5). 1276–1279. 12 indexed citations
11.
12.
Tsujino, Kazuyuki, Ryuya Edahiro, Seigo Kitada, et al.. (2018). Exercise tolerance and balance of inspiratory-to-expiratory muscle strength in relation to breathing timing in patients with chronic obstructive pulmonary disease. Journal of Breath Research. 12(3). 36008–36008. 7 indexed citations
13.
Miki, Mari, Kenji Yoshimura, Kazuyuki Tsujino, et al.. (2018). Improvement of exertional dyspnea and breathing pattern of inspiration to expiration after bronchial thermoplasty. Allergy Asthma and Clinical Immunology. 14(1). 74–74. 2 indexed citations
14.
Yano, Yukihiro, Ryuya Edahiro, Yuki Hosono, et al.. (2018). Post-progression survival after cessation of treatment with nivolumab for advanced non-small cell lung cancer: A retrospective study. PLoS ONE. 13(8). e0203070–e0203070. 6 indexed citations
15.
Uenami, Takeshi, Mikako Ishijima, Masaki Kanazu, et al.. (2018). Two cases of response to pembrolizumab in epidermal growth factor receptor mutated lung adenocarcinoma patients with programmed death-ligand 1 overexpression. Annals of Translational Medicine. 6(22). 444–444. 3 indexed citations
16.
Edahiro, Ryuya, Yuki Hosono, Kohei Nishida, et al.. (2018). Three Cases of Idiopathic Diffuse Pulmonary Ossification. Internal Medicine. 58(4). 545–551. 4 indexed citations
17.
Kanazu, Masaki, Ryuya Edahiro, Kohei Nishida, et al.. (2018). Hyperprogressive disease in patients with non‐small cell lung cancer treated with nivolumab: A case series. Thoracic Cancer. 9(12). 1782–1787. 22 indexed citations
18.
Soga, Yoshimitsu, Toshimitsu Hamasaki, Ryuya Edahiro, et al.. (2018). Sustained Effectiveness of Cilostazol After Endovascular Treatment of Femoropopliteal Lesions: Midterm Follow-up From the Sufficient Treatment of Peripheral Intervention by Cilostazol (STOP-IC) Study. Journal of Endovascular Therapy. 25(3). 306–312. 12 indexed citations
19.
Edahiro, Ryuya, Yasuhiko Sakata, Daisaku Nakatani, et al.. (2014). Association of lifestyle-related factors with circadian onset patterns of acute myocardial infarction: a prospective observational study in Japan. BMJ Open. 4(6). e005067–e005067. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shôichi Ihara Breakdown of academic impact, for papers by Chiaki Hosoda Breakdown of academic impact, for papers by T. De Greslan Breakdown of academic impact, for papers by Marie-Christine Copin Breakdown of academic impact, for papers by Gabriel O Ologun Breakdown of academic impact, for papers by Aya Wakabayashi Breakdown of academic impact, for papers by Machiko Kusuda Breakdown of academic impact, for papers by Kai-Hsiang Shu Breakdown of academic impact, for papers by Sara Bosio Breakdown of academic impact, for papers by Yahveth Cantero‐Fortiz
Rankless by CCL
2026